Latham Advises Arsenal Medical in Acquisition by Terumo Neuro

Terumo Neuro announced it has signed an agreement to acquire Arsenal Medical Inc., a privately held, clinical-stage biomaterials company developing NeoCast™, an investigational next-generation liquid embolic technology for the treatment of chronic subdural hematoma (cSDH).

Latham & Watkins LLP represents Arsenal Medical in the transaction with a corporate team led by partners Hans Brigham and Gloria Ring, with associates Peter Ernst and Ai Ni Lim. Advice was also provided on tax matters by partner Pardis Zomorodi; on regulatory matters by partner Paul Rosen, with associate Christine Kalpin; on intellectual property and data privacy matters by partner Deborah Hinck, with associates Kellye Quirk and Daniel Barks; on FDA regulatory matters by counsel Chad Jennings; on healthcare and life sciences matters by partner Betty Pang; on compensation and benefits matters by partner Josh Friedman, with associate Rebecca Fishbein; on antitrust matters by partner Patrick English, with associate Nathaniel Amann; on emerging companies matters by partner Spencer Ricks, with associate Michael Pioso; and on environmental matters by partners Devin O’Connor and Tom Lee, with associate Casey Kirk.